Taiwan · Delayed Price · Currency is TWD Ttbio Statistics
Total Valuation
Ttbio has a market cap or net worth of TWD 910.52 million. The enterprise value is 1.03 billion.
| Market Cap | 910.52M |
| Enterprise Value | 1.03B |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Ttbio has 30.05 million shares outstanding. The number of shares has increased by 12.20% in one year.
| Current Share Class | 30.05M |
| Shares Outstanding | 30.05M |
| Shares Change (YoY) | +12.20% |
| Shares Change (QoQ) | +24.46% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 5.78% |
| Float | 5.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.28 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 82.19, with an EV/FCF ratio of -21.05.
| EV / Earnings | -48.44 |
| EV / Sales | 2.59 |
| EV / EBITDA | 82.19 |
| EV / EBIT | n/a |
| EV / FCF | -21.05 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.37 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 13.95 |
| Debt / FCF | -3.57 |
| Interest Coverage | -3.89 |
Financial Efficiency
Return on equity (ROE) is -6.53% and return on invested capital (ROIC) is -4.44%.
| Return on Equity (ROE) | -6.53% |
| Return on Assets (ROA) | -2.16% |
| Return on Invested Capital (ROIC) | -4.44% |
| Return on Capital Employed (ROCE) | -4.72% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | 2.89M |
| Profits Per Employee | -154,348 |
| Employee Count | 118 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.35 |
Taxes
In the past 12 months, Ttbio has paid 171,000 in taxes.
| Income Tax | 171,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.19% in the last 52 weeks. The beta is 0.55, so Ttbio's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +77.19% |
| 50-Day Moving Average | 26.34 |
| 200-Day Moving Average | 30.73 |
| Relative Strength Index (RSI) | 59.02 |
| Average Volume (20 Days) | 219,999 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ttbio had revenue of TWD 398.88 million and -21.30 million in losses. Loss per share was -0.79.
| Revenue | 398.88M |
| Gross Profit | 70.34M |
| Operating Income | -21.23M |
| Pretax Income | -21.13M |
| Net Income | -21.30M |
| EBITDA | 4.81M |
| EBIT | -21.23M |
| Loss Per Share | -0.79 |
Balance Sheet
The company has 53.75 million in cash and 175.11 million in debt, with a net cash position of -121.36 million or -4.04 per share.
| Cash & Cash Equivalents | 53.75M |
| Total Debt | 175.11M |
| Net Cash | -121.36M |
| Net Cash Per Share | -4.04 |
| Equity (Book Value) | 357.39M |
| Book Value Per Share | 11.89 |
| Working Capital | 237.85M |
Cash Flow
In the last 12 months, operating cash flow was -41.01 million and capital expenditures -8.01 million, giving a free cash flow of -49.02 million.
| Operating Cash Flow | -41.01M |
| Capital Expenditures | -8.01M |
| Depreciation & Amortization | 26.04M |
| Net Borrowing | -62.97M |
| Free Cash Flow | -49.02M |
| FCF Per Share | -1.63 |
Margins
Gross margin is 17.63%, with operating and profit margins of -5.32% and -5.34%.
| Gross Margin | 17.63% |
| Operating Margin | -5.32% |
| Pretax Margin | -5.30% |
| Profit Margin | -5.34% |
| EBITDA Margin | 1.21% |
| EBIT Margin | -5.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.83%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.83% |
| Dividend Growth (YoY) | -33.31% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.20% |
| Shareholder Yield | -11.37% |
| Earnings Yield | -2.34% |
| FCF Yield | -5.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ttbio has an Altman Z-Score of 2.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 2 |